"Today, at the Pfizer Research and Development Center in Xianglin City, a new drug launch conference was held at the exact same time!"
"Pfizer Pharmaceutical Company also announced a new drug: Sorafenib! It's a multi-kinase inhibitor that targets VEGF and its receptors, and it's a targeted therapy drug approved by the Southern Country FDA for treating liver cancer."
"Its efficacy and effects are clearly superior to your new drug, the Yangzheng Xiujie Pill, and it's a direct competitor in the same market!"
Following this revelation from an attendee...
A large number of attendees immediately began searching for the livestream of Pfizer Pharmaceutical's global new drug launch.
Just moments ago, Lou Musaang had been proudly proclaiming this as a direct showdown between traditional Chinese medicine and Western medicine, boasting of the drug's immense safety with no drug-related adverse reactions or side effects.
